Cargando…

Verification of the Usefulness of an Assessment and Risk Control Sheet that Promotes Management of Cancer Drug Therapy

Background: Proper management of adverse events is crucial for the safe and effective implementation of anticancer drug treatment. Showa University Hospital uses our interview sheet (assessment and risk control [ARC] sheet) for the accurate evaluation of adverse events. On the day of anticancer drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Honma, O., Watanabe, C., Fukuchimoto, H., Kashiwazaki, J., Tateba, M., Wagatsuma, S., Ogata, K., Maki, K., Sonou, H., Shiga, K., Otsuka, E., Hiruta, M., Hirasawa, Y., Hosonuma, M., Murayama, M., Narikawa, Y., Toyoda, H., Tsurui, T., Kuramasu, A., Kin, M., Kubota, Y., Sambe, T., Horiike, A., Ishida, H., Shimada, K., Umeda, M., Tsunoda, T., Yoshimura, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864067/
https://www.ncbi.nlm.nih.gov/pubmed/35222016
http://dx.doi.org/10.3389/fphar.2022.744916
_version_ 1784655371303911424
author Honma, O.
Watanabe, C.
Fukuchimoto, H.
Kashiwazaki, J.
Tateba, M.
Wagatsuma, S.
Ogata, K.
Maki, K.
Sonou, H.
Shiga, K.
Otsuka, E.
Hiruta, M.
Hirasawa, Y.
Hosonuma, M.
Murayama, M.
Narikawa, Y.
Toyoda, H.
Tsurui, T.
Kuramasu, A.
Kin, M.
Kubota, Y.
Sambe, T.
Horiike, A.
Ishida, H.
Shimada, K.
Umeda, M.
Tsunoda, T.
Yoshimura, K.
author_facet Honma, O.
Watanabe, C.
Fukuchimoto, H.
Kashiwazaki, J.
Tateba, M.
Wagatsuma, S.
Ogata, K.
Maki, K.
Sonou, H.
Shiga, K.
Otsuka, E.
Hiruta, M.
Hirasawa, Y.
Hosonuma, M.
Murayama, M.
Narikawa, Y.
Toyoda, H.
Tsurui, T.
Kuramasu, A.
Kin, M.
Kubota, Y.
Sambe, T.
Horiike, A.
Ishida, H.
Shimada, K.
Umeda, M.
Tsunoda, T.
Yoshimura, K.
author_sort Honma, O.
collection PubMed
description Background: Proper management of adverse events is crucial for the safe and effective implementation of anticancer drug treatment. Showa University Hospital uses our interview sheet (assessment and risk control [ARC] sheet) for the accurate evaluation of adverse events. On the day of anticancer drug treatment, a nurse conducts a face-to-face interview. As a feature of the ARC sheet, by separately describing the symptoms the day before treatment and the day of treatment and sharing the information on the medical record, it is possible to clearly determine the status of adverse events. In this study, we hypothesized that the usefulness and points for improvement of the ARC sheet would be clarified by using and evaluating a patient questionnaire. Methods: This study included 174 patients (144 at Showa University Hospital (Hatanodai Hospital) and 30 at Showa University Koto Toyosu Hospital (Toyosu Hospital) who underwent pre-examination interviews by nurses and received cancer chemotherapy at the outpatient center of Hatanodai and Toyosu Hospital. In the questionnaire survey, the ARC sheet’s content and quality, respondents’ satisfaction, structural strengths, and points for improvement were evaluated on a five-point scale. Results: The patient questionnaire received responses from 160 participants, including the ARC sheet use group (132 people) and the non-use group (28 people). Unlike the ARC sheet non-use group, the ARC sheet use group recognized that the sheet was useful to understand the adverse events of aphthous ulcers (p = 0.017) and dysgeusia (p = 0.006). In the satisfaction survey questionnaire, there was a high sense of security in the pre-examination interviews by nurses using the ARC sheet. Conclusions: The ARC sheet is considered an effective tool for comprehensively evaluating adverse events. Pre-examination interviews by nurses using ARC sheets accurately determined the adverse events experienced by patients with anxiety and tension due to confrontation with physicians.
format Online
Article
Text
id pubmed-8864067
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88640672022-02-24 Verification of the Usefulness of an Assessment and Risk Control Sheet that Promotes Management of Cancer Drug Therapy Honma, O. Watanabe, C. Fukuchimoto, H. Kashiwazaki, J. Tateba, M. Wagatsuma, S. Ogata, K. Maki, K. Sonou, H. Shiga, K. Otsuka, E. Hiruta, M. Hirasawa, Y. Hosonuma, M. Murayama, M. Narikawa, Y. Toyoda, H. Tsurui, T. Kuramasu, A. Kin, M. Kubota, Y. Sambe, T. Horiike, A. Ishida, H. Shimada, K. Umeda, M. Tsunoda, T. Yoshimura, K. Front Pharmacol Pharmacology Background: Proper management of adverse events is crucial for the safe and effective implementation of anticancer drug treatment. Showa University Hospital uses our interview sheet (assessment and risk control [ARC] sheet) for the accurate evaluation of adverse events. On the day of anticancer drug treatment, a nurse conducts a face-to-face interview. As a feature of the ARC sheet, by separately describing the symptoms the day before treatment and the day of treatment and sharing the information on the medical record, it is possible to clearly determine the status of adverse events. In this study, we hypothesized that the usefulness and points for improvement of the ARC sheet would be clarified by using and evaluating a patient questionnaire. Methods: This study included 174 patients (144 at Showa University Hospital (Hatanodai Hospital) and 30 at Showa University Koto Toyosu Hospital (Toyosu Hospital) who underwent pre-examination interviews by nurses and received cancer chemotherapy at the outpatient center of Hatanodai and Toyosu Hospital. In the questionnaire survey, the ARC sheet’s content and quality, respondents’ satisfaction, structural strengths, and points for improvement were evaluated on a five-point scale. Results: The patient questionnaire received responses from 160 participants, including the ARC sheet use group (132 people) and the non-use group (28 people). Unlike the ARC sheet non-use group, the ARC sheet use group recognized that the sheet was useful to understand the adverse events of aphthous ulcers (p = 0.017) and dysgeusia (p = 0.006). In the satisfaction survey questionnaire, there was a high sense of security in the pre-examination interviews by nurses using the ARC sheet. Conclusions: The ARC sheet is considered an effective tool for comprehensively evaluating adverse events. Pre-examination interviews by nurses using ARC sheets accurately determined the adverse events experienced by patients with anxiety and tension due to confrontation with physicians. Frontiers Media S.A. 2022-02-09 /pmc/articles/PMC8864067/ /pubmed/35222016 http://dx.doi.org/10.3389/fphar.2022.744916 Text en Copyright © 2022 Honma, Watanabe, Fukuchimoto, Kashiwazaki, Tateba, Wagatsuma, Ogata, Maki, Sonou, Shiga, Otsuka, Hiruta, Hirasawa, Hosonuma, Murayama, Narikawa, Toyoda, Tsurui, Kuramasu, Kin, Kubota, Sambe, Horiike, Ishida, Shimada, Umeda, Tsunoda and Yoshimura. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Honma, O.
Watanabe, C.
Fukuchimoto, H.
Kashiwazaki, J.
Tateba, M.
Wagatsuma, S.
Ogata, K.
Maki, K.
Sonou, H.
Shiga, K.
Otsuka, E.
Hiruta, M.
Hirasawa, Y.
Hosonuma, M.
Murayama, M.
Narikawa, Y.
Toyoda, H.
Tsurui, T.
Kuramasu, A.
Kin, M.
Kubota, Y.
Sambe, T.
Horiike, A.
Ishida, H.
Shimada, K.
Umeda, M.
Tsunoda, T.
Yoshimura, K.
Verification of the Usefulness of an Assessment and Risk Control Sheet that Promotes Management of Cancer Drug Therapy
title Verification of the Usefulness of an Assessment and Risk Control Sheet that Promotes Management of Cancer Drug Therapy
title_full Verification of the Usefulness of an Assessment and Risk Control Sheet that Promotes Management of Cancer Drug Therapy
title_fullStr Verification of the Usefulness of an Assessment and Risk Control Sheet that Promotes Management of Cancer Drug Therapy
title_full_unstemmed Verification of the Usefulness of an Assessment and Risk Control Sheet that Promotes Management of Cancer Drug Therapy
title_short Verification of the Usefulness of an Assessment and Risk Control Sheet that Promotes Management of Cancer Drug Therapy
title_sort verification of the usefulness of an assessment and risk control sheet that promotes management of cancer drug therapy
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864067/
https://www.ncbi.nlm.nih.gov/pubmed/35222016
http://dx.doi.org/10.3389/fphar.2022.744916
work_keys_str_mv AT honmao verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT watanabec verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT fukuchimotoh verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT kashiwazakij verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT tatebam verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT wagatsumas verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT ogatak verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT makik verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT sonouh verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT shigak verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT otsukae verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT hirutam verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT hirasaway verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT hosonumam verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT murayamam verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT narikaway verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT toyodah verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT tsuruit verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT kuramasua verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT kinm verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT kubotay verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT sambet verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT horiikea verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT ishidah verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT shimadak verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT umedam verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT tsunodat verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy
AT yoshimurak verificationoftheusefulnessofanassessmentandriskcontrolsheetthatpromotesmanagementofcancerdrugtherapy